焦虑障碍治疗抵抗定义:基于德尔菲法的共识指南
该共识采用德尔菲法,由36名国际多学科专家经三轮匿名投票,就成人治疗抵抗性焦虑障碍(TR-AD)的定义达成14条推荐,涵盖药物和/或心理治疗抵抗的操作标准及分期模型,旨在为创新治疗临床试验提供统一标准。
要点
- 共识定义TR-AD的药物和/或心理治疗抵抗操作标准及分期模型。
- 共识标准为≥75%专家同意,共形成14条推荐。
- 该定义旨在促进监管临床试验和阶梯治疗算法开发。
核心结论
- 德尔菲共识提供了成人TR-AD的国际统一操作标准,有助于设计机制研究和监管临床试验。
研究设计与样本
- 基于德尔菲法的共识方法,由36名国际多学科专家和利益相关者进行三轮匿名投票。
主要发现
- 专家组就TR-AD定义达成14条推荐,包括对药物和/或心理治疗抵抗的详细操作标准及潜在分期模型。
- 专家组还评估了流行病学亚组、共病、术语(TR-AD与「难治性」焦虑障碍)、患者偏好和未来研究方向。
关键数值与推荐
- 共识定义为≥75%的专家组成员同意某陈述。
临床怎么用
- 该共识可作为系统、一致且实用的临床指南,辅助设计未来机制研究和监管临床试验。
- 最终可能促进开发更有效的循证阶梯治疗算法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anxiety disorders are very prevalent and often persistent mental disorders, with a considerable rate of treatment resistance which requires regulatory clinical trials of innovative therapeutic interventions. However, an explicit definition of treatment-resistant anxiety disorders (TR-AD) informing such trials is currently lacking. We used a Delphi method-based consensus approach to provide internationally agreed, consistent and clinically useful operational criteria for TR-AD in adults. Following a summary of the current state of knowledge based on international guidelines and an available systematic review, a survey of free-text responses to a 29-item questionnaire on relevant aspects of TR-AD, and an online consensus meeting, a panel of 36 multidisciplinary international experts and stakeholders voted anonymously on written statements in three survey rounds. Consensus was defined as ≥75% of the panel agreeing with a statement. The panel agreed on a set of 14 recommendations for the definition of TR-AD, providing detailed operational criteria for resistance to pharmacological and/or psychotherapeutic treatment, as well as a potential staging model. The panel also evaluated further aspects regarding epidemiological subgroups, comorbidities and biographical factors, the terminology of TR-AD vs. "difficult-to-treat" anxiety disorders, preferences and attitudes of persons with these disorders, and future research directions. This Delphi method-based consensus on operational criteria for TR-AD is expected to serve as a systematic, consistent and practical clinical guideline to aid in designing future mechanistic studies and facilitate clinical trials for regulatory purposes. This effort could ultimately lead to the development of more effective evidence-based stepped-care treatment algorithms for patients with anxiety disorders.
引用
- Domschke K, Seuling PD, Schiele MA, et al. The definition of treatment resistance in anxiety disorders: a Delphi method-based consensus guideline. World Psychiatry. 2024. PMID: 38214637. doi:10.1002/wps.21177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。